Pregnancy as Foreground in Cystic Fibrosis Carrier Testing Decisions in Primary Care

2009 ◽  
Vol 0 (0) ◽  
pp. 090108090224061
Author(s):  
Kathleen J.H. Sparbel ◽  
Janet K. Williams
Keyword(s):  
Primary Care ◽  
Cystic Fibrosis ◽  
Carrier Testing ◽  
Cystic Fibrosis Carrier

Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing

1996 ◽  
Vol 63 (3) ◽  
pp. 419-425 ◽  
Author(s):  
J. R. Sorenson ◽  
B. Cheuvront ◽  
A. Bruning ◽  
S. Talton ◽  
B. DeVellis ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Carrier Testing ◽  
Cystic Fibrosis Carrier

Outcomes of a cystic fibrosis carrier testing clinic for couples

2009 ◽  
Vol 191 (9) ◽  
pp. 499-501 ◽  
Author(s):  
Louise M Christie ◽  
Angela J Ingrey ◽  
Gillian M Turner ◽  
Anne L Proos ◽  
Gloria E Watts
Keyword(s):  
Cystic Fibrosis ◽  
Carrier Testing ◽  
Cystic Fibrosis Carrier

scholarly journals The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.

1997 ◽  
Vol 34 (6) ◽  
pp. 459-464 ◽  
Author(s):  
N E Hartley ◽  
D Scotcher ◽  
H Harris ◽  
P Williamson ◽  
A Wallace ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Carrier Testing ◽  
Cystic Fibrosis Carrier ◽  
In Pregnancy

Outcomes of a cystic fibrosis carrier testing clinic for couples

2010 ◽  
Vol 192 (4) ◽  
pp. 238-239
Author(s):  
Louise M Christie ◽  
Angela J Ingrey ◽  
Gillian M Turner ◽  
Anne L Proos ◽  
Gloria E Watts
Keyword(s):  
Cystic Fibrosis ◽  
Carrier Testing ◽  
Cystic Fibrosis Carrier

Verification of Performance Specifications of a Molecular Test: Cystic Fibrosis Carrier Testing Using the Luminex Liquid Bead Array

2012 ◽  
Vol 136 (1) ◽  
pp. 14-19 ◽  
Author(s):  
Felicitas L Lacbawan ◽  
Karen E Weck ◽  
Jeffrey A Kant ◽  
Gerald L Feldman ◽  
Iris Schrijver ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Drug Administration ◽  
Clinical Laboratory ◽  
Food And Drug Administration ◽  
Carrier Testing ◽  
Clinical Diagnostic Laboratory ◽  
Cystic Fibrosis Carrier ◽  
Performance Specifications ◽  
In Vitro Diagnostic

Context.—The number of clinical laboratories introducing various molecular tests to their existing test menu is continuously increasing. Prior to offering a US Food and Drug Administration–approved test, it is necessary that performance characteristics of the test, as claimed by the company, are verified before the assay is implemented in a clinical laboratory. Objective.—To provide an example of the verification of a specific qualitative in vitro diagnostic test: cystic fibrosis carrier testing using the Luminex liquid bead array (Luminex Molecular Diagnostics, Inc, Toronto, Ontario). Design.—The approach used by an individual laboratory for verification of a US Food and Drug Administration–approved assay is described. Results.—Specific verification data are provided to highlight the stepwise verification approach undertaken by a clinical diagnostic laboratory. Conclusions.—Protocols for verification of in vitro diagnostic assays may vary between laboratories. However, all laboratories must verify several specific performance specifications prior to implementation of such assays for clinical use. We provide an example of an approach used for verifying performance of an assay for cystic fibrosis carrier screening.

Sign in / Sign up

Export Citation Format

Share Document